Checking Healthcare’s Vital Signs

Baird’s experts weigh in on market opportunities and challenges

As a preview to the firm’s 2014 Healthcare Conference, several of Baird’s senior Healthcare market experts commented on today’s rapidly evolving sector. Explore the content below for timely, differentiated perspective on the current and future Healthcare environment.

 

Brian Skorney
Brian Skorney
Senior Research Analyst
Biotechnology


Biotech Valuations and the Impact of High-Price Therapies

Today’s Biotech companies are expected to develop and commercialize drugs in an increasingly complex marketplace. Brian Skorney, Senior Research Analyst, discusses the importance of pricing power, pressure to alter pricing structures and the impact of the "patent cliff" on the Biotech market.

Read the article >

Don’t Blink.

Baird Global Investment Banking on why Healthcare activity is just heating up

2014 has been a remarkable year for the Healthcare markets. Several of Baird’s veteran investment bankers share their perspective on current tailwinds and what to watch for in Biotech, Healthcare IT and Products in the balance of 2014 and beyond.

Get their market insights >

Rob Andrews
Rob Andrews
Managing Director
Healthcare Products

Trisha Renner
Trisha Renner
Managing Director
Healthcare Products
David Schechner
David Schechner
Managing Director
Head of Life Sciences Investment Banking

Bill Suddath
Bill Suddath
Managing Director
Head of Healthcare Services Investment Banking

Baird Capital's Outlook on Healthcare

The current Healthcare landscape is presenting attractive investment opportunities. Michael Bernstein, Partner in Baird Capital’s U.S. Private Equity group, shares the team’s views on four compelling areas:

  • Provider efficiency
  • Alternate site care delivery
  • Consumer-driven healthcare
  • Outcomes-based medicine

View their investment outlook >

       Michael Berstein